Contacts with children and young people and adult risk of suffering herpes zoster

Vaccine

Volumn 29, Issue 44, 2011, Pages 7602-7605

  Salleras, M ^a   Dominguez A ^b,c   Soldevila, N ^c   Prat, A ^b,d   Garrido, P ^b   Torner, N ^b,c   Borras E ^b,c   Salleras, L ^b,c,d  

^a Sagrado Corazon Hospital   (Spain)

^b UNIVERSITY OF BARCELONA   (Spain)

^c CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^d HOSPITAL CLÍNIC   (Spain)

Author keywords

Contacts with children; Herpes zoster risk in adults; Varicella vaccination; Varicella zoster virus

Indexed keywords

VARICELLA ZOSTER VACCINE;

ADULT; ADULTHOOD; AGED; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; DISEASE TRANSMISSION; ENVIRONMENTAL EXPOSURE; FEMALE; HERPES ZOSTER; HUMAN; IMMUNOCOMPETENCE; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; POPULATION EXPOSURE; PRIORITY JOURNAL; RISK; UNIVERSITY HOSPITAL;

ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; FEMALE; HERPES ZOSTER; HERPES ZOSTER VACCINE; HUMANS; MALE; MIDDLE AGED; RISK ASSESSMENT; SPAIN;

EID: 80053606977     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2011.08.023     Document Type: Article

References (24)

1. Gnann J.W., Whitley R.J. Herpes zoster. N Engl J Med 2002, 347:340-346.
2. Arvin A. Aging, immunity and the varicella-zoster virus. N Engl J Med 2005, 352:2266-2267.
3. Oxman M.N., Levin M.J., Johnson G.R., Schmader K.E., Straus S.E., Gelb L.D., et al. A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med 2005, 352:2271-2284.
4. Arvin A.M. Humoral and cellular immunity to varicella-zoster virus: an overview. J Infect Dis 2008, 197(Suppl. 2):S54-S57.
5. Hope-Simpson R.E. The nature of herpes zoster: a long-term study and a new hypothesis. Proc R Soc Med 1964, 58:9-20.
6. Arvin A.M., Koropchak C.M., Wittek A.E. Immunologic evidence of reinfection with varicella-zoster virus. J Infect Dis 1983, 148:200-205.
7. Gershon A.A., LaRussa P., Steinberg S., Mervish N., Lo S.H., Meier P. The protective effect of immunologic boosting against zoster: an analysis in leukemic children who were vaccinated against varicella. J Infect Dis 1996, 173:450-453.
8. Gershon A.A., Takahashi M., Seward J. Varicella vaccine. Vaccines 2008, 915-956. WB Saunders, Philadelphia. 5th edition. S.A. Plotkin, W.A. Orenstein (Eds.).
9. Schuette M.C., Hethcote H.W. Modelling the effects of varicella vaccination programs on the incidence of varicella and herpes zoster. Bull Math Biol 1999, 61:1031-1064.
10. Brisson M., Edmunds W.J., Gay N.J., Law B., De Serres G. Modelling the impact of immunization on the epidemiology of varicella zoster virus. Epidemiol Infect 2000, 125:651-669.
11. Brisson M., Edmunds W.J., Gay N.J. Varicella vaccination: impact of vaccine efficacy on the epidemiology of VZV. J Med Virol 2003, 70(Suppl. 1):S31-S37.
12. Brisson M., Gay N.J., Edmunds W.J., Andrews N.J. Exposure to varicella boosts immunity to herpes-zoster: implications for mass vaccination against varicella. Vaccine 2002, 20:2500-2507.
13. Schelsselman J.J. Case-control studies: design, conduct, analysis 1982, Oxford University Press, New York, p. 144-70.
14. Office of Population Censuses and Surveys Classification of occupations 1980, HMSO, London.
15. Salleras L., Domínguez A., Vidal J., Plans P., Salleras M., Taberner J.M. Seroprevalence of varicella-zoster virus infection in Catalonia (Spain). Rationale for universal vaccination programmes. Vaccine 2000, 19:183-188.
16. Salleras L., Domínguez A., Plans P., Costa J., Cardeñosa N., Torner N., et al. Seroprevalence of varicella-zoster virus infection in child and adult population of Catalonia (Spain). Med Microbiol Immunol 2008, 197:329-333.
17. Thomas S., Wheeler J., Hall A.J. Contacts with varicella or with children and protection against herpes zoster in adults: a case-control study. Lancet 2002, 360:678-682.
18. Chaves S.S., Santibanez T.A., Gargiullo P., Guris D. Varicella exposure and herpes zoster disease incidence in older adults in the U.S. Public Health Rep 2007, 122:155-159.
19. Donahue J.G., Kieke B.A., Gargiullo P.M., Jumaan A.O., Berger N.R., McCauley J.S., et al. Herpes zoster and exposure to the varicella zoster virus in an era of varicella vaccination. Ann Intern Med 2010, 152:609-611.
20. Wu C.Y., Hu H.Y., Huang N., Pu C.Y., Shen H.C., Chou Y.J. Do the health-care workers gain protection against herpes zoster infection? A 6-year population-based study in Taiwan. J Dermat 2010, 27:463-470.
21. Rimland D., Moanna A. Increasing incidence of herpes zoster among Veterans. Clin Infect Dis 2010, 50:1000-1005.
22. Carville K.S., Riddell M.A., Kelly H.A. A decline in varicella but an uncertain impact on zoster following varicella vaccination in Victoria, Australia. Vaccine 2010, 28:2532-2538.
23. Leung J., Harpaz R., Molinari N.A., Jumaan A., Zhou F. Herpes zoster incidence among insured persons in the United States, 1993-2006: evaluation of impact of varicella vaccination. Clin Infect Dis 2011, 52:332-340.
24. Yawn B.P., Saddier P., Wollan P.C., St Sauver J.L., Kurland M.J., Sy L.S. A population-based study of the incidence and complication rates of herpes zoster before zoster vaccine introduction. Mayo Clin Proc 2007, 82:1341-1349.